Literature DB >> 28573768

Nodes of Ranvier in skin biopsies of patients with diabetes mellitus.

Kathrin Doppler1, Franziska Frank1, Ann-Cathrin Koschker2, Karlheinz Reiners1, Claudia Sommer1.   

Abstract

Paranodal demyelination has been discussed as a potential mechanism of nerve fiber damage in diabetic neuropathy (DNP). Studies on human tissue are limited, as nerve biopsies are invasive and only rarely performed in patients with confirmed DNP. Skin biopsy has recently been suggested as a tool to analyze paranodal and nodal changes of myelinated fibers. We analyzed the myelinated fibers of skin biopsies of 35 patients with DNP, 17 patients with diabetes mellitus (DM) without neuropathy, and 30 normal controls. Immunofluorescence of skin sections with antibodies against Caspr, neurofascin, sodium channels, and myelin basic protein was performed to assess paranodal/nodal architecture, segmental demyelination, and myelinated nerve fibers. Staining with antibodies against protein gene product 9.5 was used to quantify unmyelinated nerve fibers. There was an increase of elongated Ranvier nodes and a dispersion of neurofascin at the distal leg in patients with DM with and without neuropathy and at the finger in patients with DNP. An increased dispersion of Caspr was only found in biopsies of the finger in patients with DNP. Skin biopsy may be an appropriate tool to analyze nodes of Ranvier in patients with DM. Structural nodal changes are detectable in DNP and even in diabetic patients without neuropathy.
© 2017 Peripheral Nerve Society.

Entities:  

Keywords:  Caspr; diabetes mellitus; diabetic neuropathy; neurofascin; node of Ranvier; skin biopsy

Mesh:

Year:  2017        PMID: 28573768     DOI: 10.1111/jns.12224

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  6 in total

1.  Methylglyoxal Disrupts Paranodal Axoglial Junctions via Calpain Activation.

Authors:  Ryan B Griggs; Leonid M Yermakov; Domenica E Drouet; Duc V M Nguyen; Keiichiro Susuki
Journal:  ASN Neuro       Date:  2018 Jan-Dec       Impact factor: 4.146

2.  Diabetes Mellitus Is a Possible Risk Factor for Nodo-paranodopathy With Antiparanodal Autoantibodies.

Authors:  Luise Appeltshauser; Julia Messinger; Katharina Starz; David Heinrich; Anna-Michelle Brunder; Helena Stengel; Bianca Fiebig; Ilya Ayzenberg; Frank Birklein; Christian Dresel; Johannes Dorst; Florian Dvorak; Alexander Grimm; Alexander Joerk; Frank Leypoldt; Mathias Mäurer; Patrick Merl; Sebastian Michels; Kalliopi Pitarokoili; Mathias Rosenfeldt; Anne-Dorte Sperfeld; Marc Weihrauch; Gabriel Simon Welte; Claudia Sommer; Kathrin Doppler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-03-21

Review 3.  The structure of sensory afferent compartments in health and disease.

Authors:  Steven J Middleton; Jimena Perez-Sanchez; John M Dawes
Journal:  J Anat       Date:  2021-09-15       Impact factor: 2.921

4.  Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule.

Authors:  Efrat Shavit-Stein; Shany Guly Gofrit; Alexandra Gayster; Yotam Teldan; Ariel Ron; Eiman Abu Bandora; Valery Golderman; Orna Gera; Sagi Harnof; Joab Chapman; Amir Dori
Journal:  Biomolecules       Date:  2020-11-13

5.  Antiparanodal antibodies and IgG subclasses in acute autoimmune neuropathy.

Authors:  Luise Appeltshauser; Anna-Michelle Brunder; Annika Heinius; Peter Körtvélyessy; Klaus-Peter Wandinger; Ralf Junker; Carmen Villmann; Claudia Sommer; Frank Leypoldt; Kathrin Doppler
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2020-07-24

6.  Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy.

Authors:  Adel Ben-Kraiem; Reine-Solange Sauer; Carla Norwig; Maria Popp; Anna-Lena Bettenhausen; Mariam Sobhy Atalla; Alexander Brack; Robert Blum; Kathrin Doppler; Heike Lydia Rittner
Journal:  J Mol Med (Berl)       Date:  2021-05-21       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.